First human tests begin for new cholesterol drug candidate
NCT ID NCT06857253
Summary
This is a first-in-human study to check the safety and how the body processes a new drug called HRS-1301. It enrolled 82 healthy adults to receive single or multiple doses. The main goal is to see what side effects occur and how long the drug stays in the blood and urine.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, 510080, China
Conditions
Explore the condition pages connected to this study.